Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Federal Trade Commission
US Department of Justice
Julphar
AstraZeneca
Novartis
Fish and Richardson
Colorcon
Daiichi Sankyo

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020833

« Back to Dashboard

NDA 020833 describes FLOVENT DISKUS 50, which is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the FLOVENT DISKUS 50 profile page.

The generic ingredient in FLOVENT DISKUS 50 is fluticasone propionate. There are twenty-six drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 020833
Pharmacology for NDA: 020833
Suppliers and Packaging for NDA: 020833
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833 NDA GlaxoSmithKline LLC 0173-0600 N 0173-0600-02
FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833 NDA GlaxoSmithKline LLC 0173-0601 N 0173-0601-00

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.05MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.1MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.25MG/INH
Approval Date:Sep 29, 2000TE:RLD:Yes

Expired US Patents for NDA 020833

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxo Grp Ltd FLOVENT DISKUS 50 fluticasone propionate POWDER;INHALATION 020833-001 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833-002 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833-002 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 100 fluticasone propionate POWDER;INHALATION 020833-002 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 50 fluticasone propionate POWDER;INHALATION 020833-001 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 250 fluticasone propionate POWDER;INHALATION 020833-003 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd FLOVENT DISKUS 50 fluticasone propionate POWDER;INHALATION 020833-001 Sep 29, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Healthtrust
Federal Trade Commission
Cantor Fitzgerald
McKesson
Express Scripts
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot